TGFB1 and neoplasm: It alleviates fibrotic responses by inhibiting TGF-β and other profibrotic factors and can significantly reduce tumor invasiveness by inhibiting EMT, regulating immune responses in the tumor microenvironment, and remodeling the ECM.